Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference53 articles.
1. Cohen AD, Wu JJ, Puig L, et al. Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice. Br J Dermatol. 2017;177(6):1495–502.
2. Carrascosa J, Jacobs I, Petersel D, Strohal R. Biosimilar drugs for psoriasis: principles, present, and near future. Dermatol Ther. 2018;8(2):173–94.
3. Radtke MA, Augustin M. Biosimilars in psoriasis: what can we expect? Biosimilars in psoriasis. J Dtsch Dermatol Ges. 2014;12(4):306–12.
4. Simoens S. Biosimilar medicines and cost-effectiveness. Clinicoecon Outcomes Res. 2011;3:29–36.
5. Biosimilars Resources Center. What is a biobetter? https://www.biosimilarsresourcecenter.org/faq/what-is-a-biobetter/. Accessed 23 Sep 2019.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献